| Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041) |
|---|
| 09/18/2008 | WO2008112851A1 Cyclopropyl fused indolobenzazepine hcv inhibitors |
| 09/18/2008 | WO2008111010A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| 09/18/2008 | US20080227981 Charge transport compositions and electronic devices made with such compositions |
| 09/18/2008 | US20080224095 lyotropic liquid crystals comprising acenaphtho[1,2-b]quinoxaline derivatives, used to form durable thin films that hardly generates cracks even when the film is exposed under a high-temperature and high-humidity environment |
| 09/18/2008 | CA2680625A1 Pyrazolo (3, 4-b) pyridine derivatives as phosphodiesterase inhibitors |
| 09/17/2008 | EP1970376A1 Imidazopyrimidine-based compound and organic light-emitting device employing organic layer including the same |
| 09/17/2008 | EP1968600A2 Rifamycin analogs and uses thereof |
| 09/17/2008 | CN101265267A Method for preparing cefozopran hydrochloride, cefozopran hydrochloride powder injection and preparation method thereof |
| 09/17/2008 | CN101265262A New oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 09/17/2008 | CN100418967C Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 09/12/2008 | WO2008108988A1 Antimicrobial heterocyclic compounds for treatment of bacterial infections |
| 09/12/2008 | WO2008107444A1 9h- purine derivatives and their use in the treatment of proliferative diseases |
| 09/12/2008 | WO2008107418A1 Fused pyrimidinone compounds as mglur ligands |
| 09/12/2008 | WO2008070507A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/12/2008 | CA2683016A1 9h- purine derivatives and their use in the treatment of proliferative diseases |
| 09/12/2008 | CA2679657A1 Antimicrobial heterocyclic compounds for treatment of bacterial infections |
| 09/12/2008 | CA2678463A1 Fused pyrimidinone compounds as mglur ligands |
| 09/10/2008 | EP1966214A1 Triazolopyridazines as tyrosine kinase modulators |
| 09/10/2008 | EP1966210A2 Sulphonamidoaniline derivatives being janus kinases inhibitors |
| 09/10/2008 | EP1966207A2 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 09/04/2008 | WO2008104387A1 Use of inhibitors of the degradation of p27, in particular argyrin and derivatives thereof, for the treatment of proliferative diseases |
| 09/04/2008 | WO2007121924A3 Bisadenosine compounds as adenosine a2a receptor agonists |
| 09/04/2008 | US20080214643 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 09/04/2008 | US20080214608 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics |
| 09/04/2008 | CA2679435A1 Use of inhibitors of the degradation of p27, in particular argyrin and derivatives thereof, for the treatment of proliferative diseases |
| 09/03/2008 | EP1964560A1 Use of inhibitors of the degradation of p27 for the treatment of cancer |
| 09/03/2008 | EP1963329A2 Inhibitors of c-met and uses thereof |
| 09/03/2008 | EP1262477B1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient |
| 09/03/2008 | CN101258157A Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 09/03/2008 | CN101255171A Intermediates of 2-substituted carbapenem derivatives and process for production thereof |
| 09/03/2008 | CN101255170A 2,3-dihydroimidazo[2,1-b]oxazole compound |
| 09/03/2008 | CN101255162A Adenosine receptor antagonists and methods of making and using the same |
| 09/02/2008 | US7420052 Intermediates for synthesis of vinblastine, process for preparation of the intermediates and process for synthesis of vinblastines |
| 09/02/2008 | US7419993 Triazolo-epothilones |
| 09/02/2008 | CA2379650C Process for producing a basic antibiotic inorganic acid salt, and oxalate intermediate |
| 08/28/2008 | WO2008103637A1 Compounds for the treatment of hepatitis c |
| 08/28/2008 | WO2008102749A1 Heterocyclic compound |
| 08/28/2008 | WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors |
| 08/28/2008 | WO2007098091A3 Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs |
| 08/28/2008 | US20080207642 Respiratory system disorders; asthma; chronic obstructive pulmonary diseases; autoimmune diseases; antiproliferative agents; anticancer agents |
| 08/28/2008 | CA2677843A1 Macrocyclic compounds as hcv ns3 protease inhibitors |
| 08/27/2008 | EP1467997B8 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 08/26/2008 | US7417156 water-soluble carboxylic acid dimers that are thermally stable and stable toward hydrolysis, less toxicity; plasmodium protozoan parasites; human malaria and Plasmodium falciparum; leukemia, lung, colon, central nervous system, ovarian, renal, prostate, and breast cancer, melanoma |
| 08/26/2008 | US7417041 Imidazopyrimidines as transforming growth factor (TGF) inhibitors |
| 08/21/2008 | WO2008098970A1 Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification |
| 08/21/2008 | US20080200456 Adenosine A2B receptor antagonists; asthma, allergies, allergic diseases or an autoimmune disease, diarrheal diseases, insulin resistance, diabetes, cancer, ischemia, reperfusion injuries, retinopathy; e.g. 1,3-Dipropyl-8-(6-chloro-3-pyridyl)xanthine |
| 08/21/2008 | CA2677269A1 Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification |
| 08/20/2008 | EP1957078A2 Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase |
| 08/20/2008 | CN101245081A Novel cephalosporin derivative |
| 08/20/2008 | CN101245080A Cephalosporin derivatives containing pyrazole triazole |
| 08/14/2008 | WO2008097796A1 Indolobenzazepine derivatives for the treatment of hepatitis c |
| 08/14/2008 | WO2007072158A8 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 08/14/2008 | US20080194590 Thrombosis therapy |
| 08/13/2008 | EP1956022A1 Compound for organic electroluminescent element and organic electroluminescent element |
| 08/13/2008 | EP1956008A1 Organic compound, charge-transporting material, composition for charge-transporting material and organic electroluminescent device |
| 08/13/2008 | EP1954697A2 Peri condensed tricyclic compounds useful as antibacterial agents |
| 08/13/2008 | EP1954268A2 Spirolactam bicyclic cgrp receptor antagonists |
| 08/13/2008 | EP1954135A2 Spirolactam aryl cgrp receptor antagonists |
| 08/13/2008 | CN101243068A Compounds for the treatment of multi-drug resistant bacterial infections |
| 08/12/2008 | US7411064 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's disease, attention deficit disorder, schizophrenia; behavioral disorders, obsessive compulsive disorders, Parkinson's disease and epilepsy |
| 08/12/2008 | US7411053 Containing substituted or unsubstituted bipyridine, tripyridine, or phenanthroline groups, e.g., Di-[p-(2,2':6',2'')terpyridin-4'-ylbenzyl] 4,4'-azobis(4-cyanovalerate) and N,N'-di-[1,10-phenanthrolin-5-yl]-4,4'-azobis(4-cyanovalerylamide); RAFT polymerization catalysts |
| 08/12/2008 | US7410961 2,6-disubstituted piperiddines as modulators |
| 08/07/2008 | WO2008094574A2 Furanone compounds and methods of making and using the same |
| 08/07/2008 | WO2008092335A1 Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives |
| 08/06/2008 | EP1953160A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists |
| 08/06/2008 | EP1951724A2 FUSED BICYCLIC mTOR INHIBITORS |
| 08/06/2008 | EP1951228A2 Bicyclic spirohydantoin cgrp receptor antagonists |
| 08/06/2008 | EP1951051A2 Spirohydantoin tricyclic cgrp receptor antagonists |
| 08/06/2008 | EP1951042A2 Spirolactam tricyclic cgrp receptor antagonists |
| 08/06/2008 | CN101235046A Novel vinblastine derivative, preparation method and use thereof, and medical composition containing the derivative |
| 08/05/2008 | US7408058 Regioisomerically pure oxochlorins and methods of synthesis |
| 08/05/2008 | US7407955 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090379A1 Pyrazoloquinazolinones as inhibitors of poly(adp-ribose)polymerase (parp) |
| 07/30/2008 | EP1725558A4 Method for preparing compounds comprising cucurbituril groups |
| 07/30/2008 | EP1326870B1 Extraction method |
| 07/30/2008 | EP1315492B1 Use of substituted pyrazoles for the treatment of allergies |
| 07/29/2008 | US7405299 Compounds as pharmaceutical agents |
| 07/29/2008 | US7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405219 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 07/29/2008 | US7405210 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase |
| 07/29/2008 | CA2515596C Cannabinoid receptor ligands and uses thereof |
| 07/24/2008 | WO2008087936A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes |
| 07/24/2008 | WO2007137030A3 Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives |
| 07/24/2008 | US20080176871 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors |
| 07/22/2008 | US7402835 Heteroatom-containing diamondoid transistors |
| 07/17/2008 | WO2008084240A1 Chemical compounds 636 : pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084236A1 Chemical compounds 635 : pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | WO2008084223A2 Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors |
| 07/17/2008 | US20080171747 Preparing 1-methyl,2-oxo,3-ethyl,4-cyclopentyl,6-chloro-1,2,3,4-tetrahydropteridine by reacting ethyl 2-N-cyclopentylaminobutyrate hydrochloride with 2,4-dichloro-5-aminopyrimidine; reducing, cyclizing and methylating by electrolytic substitution; antiproliferative, -carcinogenic and -tumor agents |
| 07/17/2008 | CA2674647A1 Chemical compounds 637 |
| 07/16/2008 | EP1944307A2 Synthetic Salicylihalamides, Apicularens and Derivatives Thereof |
| 07/15/2008 | US7399764 N-ethyl-N'-{(3R)-1-[4-(3-phenylthieno[3,4-b]pyrazin-2-yl)benzyl]pyrrolidin-3-yl}urea; inhibit activity of a serine, threonine protein kinase; cancer |
| 07/15/2008 | US7399432 Charge transport compositions and electronic devices made with such compositions |
| 07/15/2008 | CA2421120C Quinolinone derivatives as tyrosine kinase inhibitors |
| 07/10/2008 | WO2008083354A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
| 07/10/2008 | WO2008081928A1 Pyrazolopyrimidine compound |
| 07/10/2008 | WO2008081266A1 Compounds for the treatment or prevention of infection by flaviviridae |
| 07/10/2008 | WO2008051805A3 Triazolo-pyridazine protein kinase modulators |